TZIANABOS ARTHUR Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$21,700.25
Insider Sells Quantity
2
Insider Sells Sum
$1.53M

Insider Activity of TZIANABOS ARTHUR

According to the SEC Form 4 filings, TZIANABOS ARTHUR, being in a position of

  1. Interim Executive Chair at Stoke Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 4355 shares for $174,214,
    over all time since 2020-11-23, has bought 0 shares, and sold 34355 shares for $1.7M.

Biography of TZIANABOS ARTHUR

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $174,2141100

Comparison of Insiders on Amount of Buys and Sells

2026-03-10SaleStoke Therapeutics, Inc.
STOK
Interim Executive Chair
4,355
0.008%
$40.00$174,214-19.4%
2024-03-25SaleQ32 Bio Inc.
QTTB
director
265
0.0156%
$24.20$6,413+53.48%
2021-02-19SaleStoke Therapeutics, Inc.
STOK
director
10,000
0.0272%
$60.67$606,652-55.52%
2020-11-23SaleStoke Therapeutics, Inc.
STOK
director
20,000
0.0599%
$46.03$920,566-25.7%
2015-04-09PurchaseTempest Therapeutics, Inc.
TPST
President and CSO
225
0.0008%
$28.77$6,473-52.28%
2015-04-08PurchaseTempest Therapeutics, Inc.
TPST
President and CSO
175
0.0006%
$28.04$4,907-50.91%
2013-09-12PurchaseTempest Therapeutics, Inc.
TPST
Chief Scientific Officer
1,000
0.0043%
$10.32$10,320-8.12%
Total: 7
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.